CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Teva (TEVA) Reports Promising Vitiligo Trial Results And Moves Anti IL 15 Drug Forward

Data ReadoutpositiveAnti IL-15 DrugPositive
AI Analysis

Summary

Teva reported promising trial results for an anti-IL-15 drug in vitiligo and is advancing the asset further. Limited details provided in the headline-only article.

Clinical Trial Data

Importance:5/10
Sentiment:
0.65
clinical_trialvitiligoimmunologydata_readout
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 12:07 PM

Read Original